The three major U.S. stock indexes opened lower collectively.

The volume of U.S. crude oil transported through the Panama Canal is approaching its highest level in nearly four years.

Federal Reserve Governor Waller: Private credit is less likely to face bank-like runs, so the risks are lower

Weight-loss drug maker Kailera Therapeutics debuted on Nasdaq on Friday, opening at $26 per share—up 62.5% from its IPO price of $16. Intraday gains held around 57%, with its market value surpassing $2 billion.

Bernstein stated in a research report that Nvidia's upcoming Vera Rubin platform may further expand its leading position in the artificial intelligence hardware sector.